Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients

Size: px
Start display at page:

Download "Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients"

Transcription

1 2322 X. Lin et al. gy data. Journal of the American Statistical Association 1993; 88: Bodnar E, Blackstone EH. An actual problem: another issue of apples and oranges. J Thorac Cardiovasc Surg 2006; 131: Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York: Springer Verlag, Williamson PR, Kolamunnage-Dona R, Smith CT. The influence of competing-risks setting on the choice of hypothesis test for treatment effect. Biostatistics 2007; 8: Bajorunaite R, Klein JP. Comparison of failure probabilities in the presence of competing risks. J Stat Comput Simul 2008; 78: Couchoud C, Duman M, Frimat L et al. RDPLF and Rein, 2 complementary registries: a comparison of the collected data. Nephrol Ther 2007; 3: Rothman K, Greenland S. Modern Epidemiology. Philadelphia: Lippincott-aven, Siva B, Hawley CM, McDonald SP et al. Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol 2009; 4: Miles R, Hawley CM, McDonald SP et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 2009; 76: Andersen PK, Abildstrom SZ, Rosthoj S. Competing risks as a multistate model. Stat Methods Med Res 2002; 11: Cook RJ, Lawless JF. Marginal analysis of recurrent events and a terminating event. Stat Med 1997; 16: Dauxois JY, Sencey S. Non-parametric tests for recurrent events under competing risks. Scandinavian Journal of Statistics 2009; 36: Sozio SM, Armstrong PA, Coresh J et al. Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Am J Kidney Dis 2009; 54: Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 2007; 40: Received for publication: ; Accepted in revised form: Nephrol Dial Transplant (2010) 25: doi: /ndt/gfq001 Advance Access publication 29 January 2010 Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients Xinghui Lin 1, Aiwu Lin 1, Zhaohui Ni 1, Qiang Yao 2, Weiming Zhang 1, Yucheng Yan 1, Wei Fang 1, Aiping Gu 1, Jonas Axelsson 3 and Jiaqi Qian 1 1 Renal Division, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Center for Peritoneal Dialysis Research, Shanghai, China, 2 Baxter Renal, China and 3 Department of Clinical Science, Karolinska Institutet, Stockholm, Sweden Correspondence and offprint requests to: Jiaqi Qian; jiaqiqian@126.com Abstract Background. Maintenance dialysis therapy is the only way to remove excess fluid in patients with anuric end-stage renal disease. The optimal ultrafiltration (UF) volume in patients on peritoneal dialysis (PD) remains controversial. Methods. We retrospectively analysed a cohort of 86 prevalent anuric PD patients followed up for a median of 25.3 months (range, 6 to 54 months). Clinical and PD parameters were recorded yearly. Kaplan Meier analysis and Cox proportional hazards models were used to identify risk factors of mortality and technique failure in patients with a UF 1 L/24 h or <1 L/24 h. Results. When compared to those with a UF <1 L/24 h, patients with a UF 1 L/24 h had significantly higher haemoglobin levels (101.9 ± 20.5 vs 89.3 ± 20.2 g/l, P < 0.05) and tended to be younger (55.0 ± 12.5 vs 60.6 ± 16.1 years, P = 0.10). Also, while Kt/V and CCr were stable over time, UF decreased significantly over the study period (baseline, ± ml/24 h vs after 3 years, ± ml/24 h; P < 0.001). Using Kaplan Meier analysis, patients with baseline UF <1 L/24 h had significantly worse outcome (survival, 27.2 ± 3.9 vs 42.4 ± 1.9 months; P < 0.001). In multivariate Cox regression analysis, age, time-dependent UF volume and serum albumin were independent predictors of mortality, while UF independently predicted technique failure. Conclusions. The present study demonstrates a strong predictive value of daily peritoneal UF for both technique and patient survival in prevalent anuric PD patients. Identifying markers of satisfactory fluid status, as well as optimizing therapy to meet UF goals, remains an important clinical target. Keywords: anuria; patient survival; peritoneal dialysis; technique survival Introduction Over the past four decades, peritoneal dialysis (PD) has been an important form of renal replacement therapy for patients with end-stage renal disease (ESRD). Previous The Author Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please journals.permissions@oxfordjournals.org

2 Daily peritoneal UF predicts patient and technique survival 2323 Table 1. Baseline data of 86 anuric PD patients divided by calculated peritoneal UF All patients UF 1 L/24 h UF <1 L/24 h P-value No. of patients Gender (M:F) 37:49 29:37 8:12 Age (years) 56.3 ± ± ± 16.1 NS Previous months on PD (months) 41.4 ± ± ± 24.8 NS Haemoglobin (g/l) 99.0 ± ± ± 20.2 <0.05 Systolic BP (mmhg) ± ± ± 25.7 NS Diastolic BP (mmhg) 86.1 ± ± ± 14.5 NS Instilled dialysate volume (L) 7.60 ± ± ± 0.98 NS Urine output (ml/24 h) 23.6 ± ± ± 44.7 NS BUN (mmol/l) 21.2 ± ± ± 6.7 NS Scr (µmol/l) ± ± ± NS Kt/V urea 1.75 ± ± ± 0.31 NS CCr (L/week/1.73 m 2 ) 46.2 ± ± ± 10.6 NS Serum albumin (g/l) 36.5 ± ± ± 4.5 NS UF rate (ml/24 h) ± ± ± <0.001 Diabetic status, n (%) 20 (23.3) 14 (21.2) 6 (30.0) NS D/P Cr 0.62 ± ± ± 0.11 NS Renal diagnosis Chronic glomerulonephritis Diabetic nephropathy Hypertensive nephrosclerosis Polycystic kidney disease Lupus nephritis Other/unknown Data are expressed as mean ± SD, P-values result from comparisons of baseline values of the two groups divided by baseline UF. BUN, blood urea nitrogen; Scr, serum creatinine; CCr, total weekly creatinine clearance; UF, ultrafiltration; NS, not significant. studies have reported similar patient survival rates for PD and haemodialysis when appropriate adjustments are made for differences in case mix [1]. However, a number of studies have shown that fluid overload is prevalent in PD patients, especially in patients who have lost their residual renal function (RRF) [2 4]. Inadequate fluid removal in this population contributes to hypertension and is associated with an increased risk of cardiovascular disease [5], hypoalbuminaemia [6] and systemic inflammation [7]. Indeed, reanalysis of the large CANUSA study has shown that the decrease in RRF, rather than peritoneal creatinine clearance, best predicts both mortality and morbidity in PD patients [8]. According to this analysis, every increase of 250 ml in urine output leads to a 36% decrease in mortality risk [8], again suggesting the important role of fluid status in predicting clinical outcome. Ultrafiltration (UF) over the peritoneal membrane during dialysis is the standard therapy for removing excess fluid in anuric patients on PD, but the optimal UF volume in this population remains controversial. The European Best Practice Guideline Working Group on Peritoneal Dialysis set an arbitrary target that the minimum net UF in anuric PD patients should be 1 L/day [9]. However, the International Society for Peritoneal Dialysis believes that no numerical target for UF can be formulated using the present data [10]. In the present study, we performed a retrospective cohort study of prevalent anuric PD patients in our centre. We aimed to study the impact of attaining peritoneal UF targets on clinical outcome in anuric Chinese patients. Materials and methods Patient selection We retrospectively evaluated 86 prevalent anuric PD patients from the PD unit of Renji Hospital who became anuric between 1 January 2003 and 31 October 2007 and followed them up for a median of 25.3 months (range, 6 to 54 months) until 30 April Anuria was defined as a 24-h urine output of 100 ml. All patients were regularly monitored in our centre and had started their PD treatment at least 6 months before enrolment. Exclusion criteria were survival <6 months, transfer to haemodialysis or kidney transplantation within 6 months, having an active systemic inflammatory disease and/or having unstable organ disease, such as hepatic failure or class 3 4 according to the New York Heart Association Classification for congestive heart failure. Baseline data including age, sex, aetiology of renal disease, PD regimen, duration on dialysis before enrolment, presence of diabetes mellitus and blood pressure (BP) were recorded. All of the included patients were prescribed a glucose-based PD solution with at least three 2-L exchanges per day. Most were receiving other drugs common in ESRD, including antihypertensive medication, erythropoietin and phosphorus binders. Data collection Dialysis adequacy was monitored at least yearly by 24-h dialysate collections [11], UF rate was calculated as the difference between the volume of total dialysate infused and the volume drained over 24 h and daily UF was corrected for overfill. Adequacy of dialysis was estimated by measurement of weekly Kt/V urea and weekly creatinine clearance (CCr) using PD-ADEQUEST (Baxter Healthcare Corporation, Chicago, IL, USA). We also assessed peritoneal equilibration test [12] yearly. Biochemical tests including blood urea nitrogen (BUN), serum creatinine, glucose, calcium and phosphorus levels and serum albumin were also examined using standard equipment (ADVIA1650, Bayer Corporation) for the same period. The POET and PD-ADEQUEST software (Baxter Healthcare Corporation, Chicago, IL, USA) were used to assist with data management.

3 2324 X. Lin et al. Table 2. Longitudinal changes in small solute clearance, albumin level, UF rate, instilled dialysate volume and content of glucose in dialysate during the study period, and grouped according to follow-up time and baseline UF 1 L/24 h and <1 L/24 h Follow-up Baseline One year Two years Three years No. of patients Kt/V urea 1.75 ± ± ± ± 0.35 UF 1 L/24 h 1.77 ± ± ± ± 0.24 UF <1 L/24 h 1.70 ± ± ± ± 0.59 CCr (L/week/1.73 m 2 ) 46.2 ± ± ± ± 10.4 UF 1 L/24 h 46.7 ± ± ± ± 7.2 UF <1 L/24 h 44.5 ± ± ± ± 13.6 Serum albumin (g/l) 36.5 ± ± ± ± 3.6 UF 1 L/24 h 36.9 ± ± ± ± 3.5 UF <1 L/24 h 35.3 ± ± ± ± 4.4 UF rate (ml/24 h) ± ± ± 310.2* ± 439.8* UF 1 L/24 h ± ± ± ± UF <1 L/24 h ± ± ± ± Instilled dialysate volume (L/day) 7.60 ± ± ± ± 1.15 UF 1 L/24 h 7.70 ± ± ± ± 1.24 UF <1 L/24 h 7.30 ± ± ± ± 1.00 Content of glucose in dialysate (g/day) ± ± ± ± 44.7 UF 1 L/24 h ± ± ± ± 44.1 UF <1 L/24 h ± ± ± ± 52.5 D/P Cr 0.62 ± ± ± ± 0.12 UF 1 L/24 h 0.61 ± ± ± ± 0.11 UF <1 L/24 h 0.66 ± ± ± ± 0.14 CCr, total weekly creatinine clearance; UF, ultrafiltration. * P < 0.001, compared with baseline data, ANOVA. Statistical analysis Statistical analysis was performed using SPSS 15.0 for Windows (SPSS Inc., Chicago, IL, USA). Results are expressed as mean ± SD. Comparison of means and percentages was performed using paired and unpaired ANOVA or a chi-square test. Correlations were analysed using Pearson s correlation coefficient. The Cox proportional hazards model was used for statistical analysis of survival. Baseline parameters with a P-value <0.05 in univariate Cox regression were then incorporated into a final multivariate Cox regression analysis. Backward stepwise elimination using the Wald test was applied to remove insignificant variables. UF was treated as a time-dependent variable in the final Cox model. Similarly, we performed the same analysis to assess associations between clinical parameters and technique failure, defined as transfer to haemodialysis or death. We also performed Kaplan Meier survival analysis; dividing the patients according to baseline UF 1 L/24 h or <1 L/24 h, which coincided with the UF target recommended by the European Best Practice Guideline Working Group on Peritoneal Dialysis [9], a ROC curve was made to determine the sensitivity and specificity of UF in predicting mortality. Results Baseline characteristics Eighty-six patients were enrolled, with a median follow-up of 25.3 ± 12.4 months. Baseline clinical characteristics are Table 3. RR of death in univariate Cox regression for selected variables at baseline in 86 anuric PD patients RR 95% CI P-value Age (1 year) <0.001 Gender (female) NS Previous months on PD (1 month) NS Systolic BP (10 mmhg) <0.01 Diastolic BP (10 mmhg) NS BUN (1 mmol/l) <0.01 Scr (100 µmol/l) <0.01 Kt/V urea (0.1 unit/week) NS CCr (1 L/week/1.73 m 2 ) NS Haemoglobin (1 g/l) NS Serum albumin (1 g/l) <0.001 UF rate (100 ml/24 h) <0.001 Diabetic status (present) <0.01 D/P Cr (0.1) NS BUN, blood urea nitrogen; Scr, serum creatinine; CCr, total weekly creatinine clearance; UF, ultrafiltration; NS, not significant. summarized in Table 1. Briefly, compared to patients with a UF <1 L/24 h, patients with a UF 1 L/24 h had signif-

4 Daily peritoneal UF predicts patient and technique survival 2325 Table 4. Multivariate Cox regression analysis showing independent predictors of mortality in 86 anuric PD patients followed up for a median of 25.3 months (range, 6 to 54 months) Table 5. Multivariate Cox regression analysis showing independent predictors of technique failure in 86 anuric PD patients followed up for a median of 25.3 months (range, 6 to 54 months) RR 95% CI P-value Age (1 year) Serum albumin (1 g/l) UF(t) (100 ml/24 h) The original model included age, systolic BP, serum albumin, diabetic status and time-dependent UF. RR 95% CI P-value Serum albumin (1 g/l) UF(t) (100 ml/24 h) Systolic BP (mmhg) The original model included age, systolic BP, serum albumin, diabetic status and time-dependent UF. icantly higher haemoglobin levels (101.9 ± 20.5 g/l vs 89.3 ± 20.2 g/l, respectively; P < 0.001) and tended to be younger (55.0 ± 12.5 years vs 60.6 ± 16.1 years, respectively; P = 0.10). Longitudinal data During the study period, 40 patients dropped out. Ten patients were switched to haemodialysis, four patients received transplants and 26 died. Cardiovascular disease was the leading cause of death, while infection was the second most common cause of death. Eight patients were transferred to haemodialysis due to severe peritonitis, one due to hernia and one due to inadequate dialysis. Table 2 shows the longitudinal changes in dialysis adequacy parameters as well as serum albumin level, UF rate, instilled dialysate volume, input glucose content and dialysate/plasma creatinine ratio (D/P Cr) at baseline and during the study period. Briefly, despite the fact that instilled dialysate volume and input glucose content tended to increase with time, UF decreased significantly (baseline, ± ml vs after 3 years, ± ml; P < 0.001). While D/P Cr tended to increase after 3 years, none of the other markers changed during follow-up Survival analysis The relative risks (RRs) of death associated with baseline parameters are summarized in Table 3. Briefly, age, systolic BP, BUN, serum creatinine, serum albumin, diabetic status and UF rate were each predictors of death in univariate analysis, whereas neither Kt/V urea nor CCr predicted mortality. In multivariate Cox analysis (Table 4), age, baseline albumin and time-dependent UF rate were each independent predictors of mortality. Likewise, Kaplan Meier analysis showed that patients with a UF above 1 L/24 h survived significantly longer than those with a UF below 1 L/24 h (median survival, 42.4 ± 1.9 vs 27.2 ± 3.9 months; P < 0.001) (Figure 1). The UF ROC curve showed that the area under the curve is (P < 0.001); when UF is equal to 1.0 L/day, the sensitivity of UF in predicting mortality is between (UF = 1025 ml/24 h) and (UF = 975 ml/24 h) and the specificity is between (UF = 975ml/24 h) and (UF = 1025 ml/24 h). Technique survival Table 5 shows independent predictors of technique failure analysed using a Cox model and only time-dependent rate was found to predict technique failure. Figure 2 shows the Kaplan Meier estimates of technique survival, which suggests that patients with a baseline UF 1 L/24 h had statistically significant better technique survival compared with those with a baseline UF <1 L/24 h (median survival, 37.8 ± 2.0 vs 26.3 ± 3.8 months; P = 0.002) Cum Survival Log rank test P <0.001 Cum Survival Log rank test P < Months Fig. 1. Kaplan Meier survival curves for all-cause mortality in 86 anuric PD patients grouped according to baseline UF of 1 L/24 h (dashed) and <1 L/24 h (solid); P < Months Fig. 2. Kaplan Meier survival curves of technique survival in 86 anuric PD patients grouped according to baseline UF of 1 L/24 h (dashed) and <1 L/24 h (solid); P < 0.01.

5 2326 X. Lin et al. Discussion In a retrospective analysis of PD patients that became anuric and were followed up for a median of 25.3 months, we confirm the strong prognostic value of peritoneal UF. In fact, compared to other commonly used markers of dialysis adequacy such as Kt/V urea and CCr, UF was a more potent predictor of both mortality and technique failure in our analysis. This finding was in agreement with previous studies. Ates et al. have found that total fluid removal including UF and urine output was an independent predictor of patient survival [13], whereas Kt/V urea and CCr were not predictors. While the European APD Outcome Study (EA- POS) found that a baseline UF <750 ml/24 h, but not CCr, predicted a poor survival in anuric automated PD patients [14]. Additionally, the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) also related peritoneal UF to survival in anuric patients on PD [15]. All of these studies were performed on mainly non-asian populations; as it is well-known that Asian patients tend to preserve their peritoneal function longer on PD [16], we demonstrated that UF also strongly influenced clinical outcome in anuric Chinese patients on PD. Unfortunately, a number of studies have shown that a dysfunction of UF is not rare in long-term PD [17,18]. The present study also found that UF volume gradually decreased with time despite that fact that instilled dialysate volume and input glucose content tended to increase. The precise mechanism of this phenomenon remains to be elucidated, but a frequent peritonitis and the bioincompatible PD solutions such as high glucose, hyperosmolality, low ph and glucose degradation products leading to a high peritoneal transport status or peritoneal fibrosis are thought to be responsible for this. Several studies have shown that the dysfunction of UF was a leading cause of PD dropout [19,20]. The impaired UF capacity aggravates the volume expansion and consequent poor survival rate despite having good urea and creatinine clearance [21 23]. It should be pointed out that patients with obvious oedema and incurable hypertension in our unit are informed to restrict their water and sodium intake. However, some patients with subclinical volume expansion due to unconsciously impaired UF are likely to drink too much. Thus far, the optimal UF volume in anuric patients on PD remains controversial [9,10]. Theoretically, a target of UF in anuric PD patients seems to be logical, which will facilitate a timely therapeutic intervention when UF declines to a dangerous level while the patient is only in asymptomatic fluid overload status. In the present study, a Kaplan Meier survival analysis indicated that a baseline UF <1 L/24 h was associated with significantly higher mortality and technical failure than a baseline UF over 1 L/24 h. This finding demonstrates a strong predictive value of peritoneal daily UF for clinical outcome in anuric patients on PD. Interestingly, we did find that few of the surviving patients with strictly restricted water and sodium intake had a baseline UF <1 L/24 h over 2 years of follow-up. Thus, it could be deduced that the better prognosis of patients with UF over 1 L/24 h is likely to be associated with an adequate fluid removal which leads to a better fluid balance. Similar to the findings from other studies [24 26], we found that a decrease of albumin was significantly associated with poor survival. We also noticed that patients with UF <1 L/24 h had significantly lower haemoglobin levels and tended to be hypoalbuminaemic compared with others with better UF. We speculated that the lower haemoglobin and hypoalbuminaemia in patients with less UF was in part related to fluid overload, as previous studies have shown that volume expansion in PD patients would contribute to hypoalbuminaemia [6]. We failed to demonstrate that Kt/V urea is a predictor of clinical outcome in anuric patients, a result that is similar with that of EAPOS [14]. However, this does not mean that Kt/V urea is unimportant; it is noticeable that the median value of Kt/V urea, either in surviving patients or in deceased patients (1.77 ± 0.31 vs 1.70 ± 0.26, P > 0.05), has reached 1.7, a minimum target recommended by K/ DOQI [27]. Our previous study found that when Kt/V urea was <1.7, the PD patients had worse survival than those having higher Kt/V urea values [28]. In any case, a combination of Kt/V urea and other important factors such as UF and fluid balance should be used to determine the adequacy of dialysis. The limitations of the present study include its design with a relatively small number of patients and the fact that it was a retrospective study, not a prospective study. Moreover we do not have any objective marker of fluid status in these patients. In spite of these shortcomings, this study could provide some useful information based on a realworld practice, performed in a single centre in Chinese population, which excluded the centre effect and any ethical differences regarding prognosis. Conclusion In conclusion, we confirm the previously reported strong prognostic impact of peritoneal UF in anuric PD patients and we demonstrate a strong predictive value of daily peritoneal UF for both technique and patient survival in this population. While current guidelines do not adequately address the optimum UF target in anuric patients on PD, identifying markers of satisfactory fluid status, as well as optimizing therapy to meet UF goals, remains an important clinical target. Acknowledgments. This study was supported in part by the Shanghai Commission of Science and Technology (no. 08dz ). Conflict of interest statement. None declared. References 1. Fenton SSA, Schanbel DE, Desmeules M et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30: Rottembourg J. Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int 1993; 43: S106 S Lameire N, Vanholder RC, Van Loo A et al. Cardiovascular diseases in peritoneal dialysis patients: the size of the problem. Kidney Int 1996; 50: S28 S36

6 Daily peritoneal UF predicts patient and technique survival Tzamaloukas AH, Saddler MC, Murata GH et al. Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am Soc Nephrol 1995; 6: Silberberg JS, Barre P, Prichard S et al. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: Jones CH, Smye SW, Newstead CG et al. Extracellular fluid volume determined by bioelectric impedance and serum albumin in CAPD patients. Nephrol Dial Transplant 1998; 13: Chung SH, Heimburger O, Stenvinkel P et al. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 2001; 16: Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. JAmSocNephrol2001; 12: The European Best Practice Guideline Working Group on Peritoneal Dialysis: adequacy of peritoneal dialysis. Nephrol Dial Transplant 2005; 20: ix24 ix Lo WK, Bargman JM, Burkart J et al. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int 2006; 26: Szeto CC, Wong TY, Leung CB et al. Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 2000; 58: Twardowski ZJ, Nolph KD, Khanna R et al. Peritoneal equilibration test. Perit Dial Int 1987; 7: Ates K, Nergizoglu G, Keven K et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60: Brown EA, Davies SJ, Rutherford P et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14: Jansen MA, Termorshuizen F, Korevaar JC et al. Predictors of survival in anuric peritoneal dialysis patients. Kidney Int 2005; 68: Pei YP, Greenwood CM, Chery AL et al. Racial differences in survival of patients on dialysis. Kidney Int 2000; 58: Davies SJ, Bryan J, Phillips L et al. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996; 11: Heimburger O, Waniewski J, Werynski A et al. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990; 38: Korbet SM, Rodby RA. Peritoneal membrane failure: differential diagnosis, evaluation, and treatment. Semin Dial 1994; 7: Kawaguchi Y, Hasegawa T, Nakayama M et al. Issues affecting the longevity of the continuous peritoneal dialysis therapy. Kidney Int 1997; 52: S105 S Wang T, Heimbürger O, Waniewski J et al. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998; 13: Bos WJ, Struijk DG, van Olden RW et al. Elevated 24-hour blood pressure in peritoneal dialysis patients with ultrafiltration failure. Adv Perit Dial 1998; 14: Churchill DN, Thorpe KE, Nolph KDA et al. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-U.S.A. (CANUSA) Peritoneal Dialysis Study Group. JAmSoc Nephrol 1998; 9: Churchill DN, Taylor DW, Keshaviah PR. The Canada-USA (CANU- SA) Peritoneal Dialysis Study Group: adequacy of dialysis and nutrition in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 1996; 7: Szeto CC, Wong TYH, Chow KM et al. Impact of dialysis adequacy on the mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2001; 12: Paniagua R, Amato D, Vonesh E et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: Peritoneal Dialysis Adequacy Work Group. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 2006; 48: S98 S Yao Q, Lin A, Qian et al. The adequacy of peritoneal dialysis in a single Chinese center. Hong Kong J Nephrol 2001; 3: Received for publication: ; Accepted in revised form:

Peritoneal Dialysis Adequacy: Not Just Small- Solute Clearance

Peritoneal Dialysis Adequacy: Not Just Small- Solute Clearance Advances in Peritoneal Dialysis, Vol. 24, 2008 Rajesh Yalavarthy, Isaac Teitelbaum Peritoneal Dialysis Adequacy: Not Just Small- Solute Clearance Two indices of small-solute clearance, Kt/V urea and creatinine

More information

3/21/2017. Solute Clearance and Adequacy Targets in Peritoneal Dialysis. Peritoneal Membrane. Peritoneal Membrane

3/21/2017. Solute Clearance and Adequacy Targets in Peritoneal Dialysis. Peritoneal Membrane. Peritoneal Membrane 3/21/2017 Solute Clearance and Adequacy Targets in Peritoneal Dialysis Steven Guest MD Director, Medical Consulting Services Baxter Healthcare Corporation Deerfield, IL, USA Peritoneal Membrane Image courtesy

More information

PART ONE. Peritoneal Kinetics and Anatomy

PART ONE. Peritoneal Kinetics and Anatomy PART ONE Peritoneal Kinetics and Anatomy Advances in Peritoneal Dialysis, Vol. 22, 2006 Paul A. Fein, Irfan Fazil, Muhammad A. Rafiq, Teresa Schloth, Betty Matza, Jyotiprakas Chattopadhyay, Morrell M.

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Peritoneal transport and ultrafiltration GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Peritoneal transport and ultrafiltration GUIDELINES Date written: January 2004 Final submission: May 2004 Peritoneal transport and ultrafiltration GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES Date written: August 2004 Final submission: July 2005 Monitoring patients on peritoneal dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions

More information

Early Estimation of High Peritoneal Permeability Can Predict Poor Prognosis for Technique Survival in Patients on Peritoneal Dialysis

Early Estimation of High Peritoneal Permeability Can Predict Poor Prognosis for Technique Survival in Patients on Peritoneal Dialysis Advances in Peritoneal Dialysis, Vol. 22, 2006 Hidetomo Nakamoto, 1,2 Hirokazu Imai, 2 Hideki Kawanishi, 2 Masahiko Nakamoto, 2 Jun Minakuchi, 2 Shinichi Kumon, 2 Syuichi Watanabe, 2 Yoshhiko Shiohira,

More information

Advances in Peritoneal Dialysis, Vol. 23, 2007

Advances in Peritoneal Dialysis, Vol. 23, 2007 Advances in Peritoneal Dialysis, Vol. 23, 2007 Antonios H. Tzamaloukas, 1,2 Aideloje Onime, 1,2 Dominic S.C. Raj, 2 Glen H. Murata, 1 Dorothy J. VanderJagt, 3 Karen S. Servilla 1,2 Computation of the Dose

More information

Predictors of Patient Survival in Continuous Ambulatory Peritoneal Dialysis 10-Year Experience in 2 Major Centers in Tehran

Predictors of Patient Survival in Continuous Ambulatory Peritoneal Dialysis 10-Year Experience in 2 Major Centers in Tehran Dialysis Predictors of Patient Survival in Continuous Ambulatory Peritoneal Dialysis 10-Year Experience in 2 Major Centers in Tehran Monir Sadat Hakemi, 1 Mehdi Golbabaei, 2 Amirahmad Nassiri, 3 Mandana

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES Date written: September 2004 Final submission: February 2005 Mode of dialysis at initiation GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions

More information

The greatest benefit of peritoneal dialysis (PD) is the

The greatest benefit of peritoneal dialysis (PD) is the Peritoneal Dialysis International, Vol. 26, pp. 150 154 Printed in Canada. All rights reserved. 0896-8608/06 $3.00 +.00 Copyright 2006 International Society for Peritoneal Dialysis COMBINATION THERAPY

More information

Ana Paula Bernardo. CHP Hospital de Santo António ICBAS/ Universidade do Porto

Ana Paula Bernardo. CHP Hospital de Santo António ICBAS/ Universidade do Porto Ana Paula Bernardo CHP Hospital de Santo António ICBAS/ Universidade do Porto Clinical relevance of hyperphosphatemia Phosphate handling in dialysis patients Phosphate kinetics in PD peritoneal phosphate

More information

Effect of Initial PET Status on Clinical Course in Peritoneal Dialysis Patients

Effect of Initial PET Status on Clinical Course in Peritoneal Dialysis Patients BANTAO Journal 2015; 13(1): 14-19; doi:10.1515/bj-2015-0004 BJ BANTAO Journal Original article Effect of Initial PET Status on Clinical Course in Peritoneal Dialysis Patients Tamer Sakaci¹, Yener Koc²,

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Level of renal function at which to initiate dialysis GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Level of renal function at which to initiate dialysis GUIDELINES Level of renal function at which to initiate dialysis Date written: September 2004 Final submission: February 2005 GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR

More information

Methods. Original Article. Abstract

Methods. Original Article. Abstract Original Article Influence of Peritoneal Transport Characteristics on Nutritional Status and Clinical Outcome in Chinese Diabetic Nephropathy Patients on Peritoneal Dialysis Ji Chao Guan 1,2, Wei Bian

More information

Chapter 2 Peritoneal Equilibration Testing and Application

Chapter 2 Peritoneal Equilibration Testing and Application Chapter 2 Peritoneal Equilibration Testing and Application Francisco J. Cano Case Presentation FW, a recently diagnosed patient with CKD Stage 5, is a 6-year-old boy who has been recommended to initiate

More information

Original Article. Key words: Icodextrin, peritoneal dialysis, metabolic effects, ultrafiltration

Original Article. Key words: Icodextrin, peritoneal dialysis, metabolic effects, ultrafiltration Original Article 133 Clinical Experience of One-Year Icodextrin Treatment in Peritoneal Dialysis Patients Chun-Shuo Hsu *, Chien-Yu Su **, Chih-Hung Chang ***, Kao-Tai Hsu **, King-Kwan Lam **, Shang-Chih

More information

Objectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring

Objectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring Peritoneal Dialysis Prescription and Adequacy Monitoring Christine B. Sethna, MD, EdM Division Director, Pediatric Nephrology Cohen Children s Medical Center Associate Professor Hofstra Northwell School

More information

Adequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled trial

Adequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled trial http://www.kidney-international.org & 2006 International Society of Nephrology original article Adequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled

More information

Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations

Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations NDT Advance Access published November 9, 2005 Nephrol Dial Transplant (2005) 1 of 8 doi:10.1093/ndt/gfi248 Original Article Effect of previously failed kidney transplantation on peritoneal dialysis outcomes

More information

Advances in Peritoneal Dialysis, Vol. 29, 2013

Advances in Peritoneal Dialysis, Vol. 29, 2013 Advances in Peritoneal Dialysis, Vol. 29, 2013 Takeyuki Hiramatsu, 1 Takahiro Hayasaki, 1 Akinori Hobo, 1 Shinji Furuta, 1 Koki Kabu, 2 Yukio Tonozuka, 2 Yoshiyasu Iida 1 Icodextrin Eliminates Phosphate

More information

PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT GUIDE

PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT GUIDE PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT GUIDE TABLE OF CONTENTS Introduction.... 3 SECTION 1: FUNDAMENTALS OF THE PRESCRIPTION.... 4 Getting Started: Patient Pathway to First Prescription.... 5 Volume

More information

Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study

Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study Kidney International, Vol. 64 (2003), pp. 649 656 DIALYSIS TRANSPLANTATION Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study WAI-KEI LO, YIU-WING HO, CHUN-SANG

More information

2016 Annual Dialysis Conference Michelle Hofmann RN, BSN, CNN Renal Clinical Educator - Home

2016 Annual Dialysis Conference Michelle Hofmann RN, BSN, CNN Renal Clinical Educator - Home Fluid Management 2016 Annual Dialysis Conference Michelle Hofmann RN, BSN, CNN Renal Clinical Educator - Home Objectives Define euvolemia Determine factors which contribute to fluid imbalance Discuss strategies

More information

PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE

PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE This quick reference guide will help serve as a reference tool for clinicians setting a patient s Peritoneal Dialysis (PD) prescription.

More information

Maintaining Peritoneal Dialysis Adequacy: The Process of Incremental Prescription

Maintaining Peritoneal Dialysis Adequacy: The Process of Incremental Prescription Advances in Peritoneal Dialysis, Vol. 34, 2018 Susie Q. Lew Maintaining Peritoneal Dialysis Adequacy: The Process of Incremental Prescription Urea kinetics (weekly Kt/V) greater than 1.7 generally define

More information

Peritoneal Dialysis International, Vol. 16, pp /96$300+00

Peritoneal Dialysis International, Vol. 16, pp /96$300+00 Peritoneal Dialysis International, Vol. 16, pp 302-306 0896-8608/96$300+00 Printed in Canada All rights reserved Copyright 1996 International Society for Peritoneal Dialysis CONTINUOUS PERITONEAL DIAL

More information

Effect of fluid and sodium removal on mortality in peritoneal dialysis patients

Effect of fluid and sodium removal on mortality in peritoneal dialysis patients Kidney International, Vol. 60 (2001), pp. 767 776 Effect of fluid and sodium removal on mortality in peritoneal dialysis patients KENAN ATEŞ, GÖKHAN NERGİZOĞLU, KENAN KEVEN, ARZU ŞEN, SIM KUTLAY, ŞEHSUVAR

More information

Hyperphosphatemia is a strong predictor of overall

Hyperphosphatemia is a strong predictor of overall Peritoneal Phosphate Clearance is Influenced by Peritoneal Dialysis Modality, Independent of Peritoneal Transport Characteristics Sunil V. Badve,* Deborah L. Zimmerman,* Greg A. Knoll, * Kevin D. Burns,*

More information

Intravenous Iron Does Not Affect the Rate of Decline of Residual Renal Function in Patients on Peritoneal Dialysis

Intravenous Iron Does Not Affect the Rate of Decline of Residual Renal Function in Patients on Peritoneal Dialysis Advances in Peritoneal Dialysis, Vol. 22, 2006 Hemal Shah, Ashutosh Shukla, Abirami Krishnan, Theodore Pliakogiannis, Mufazzal Ahmad, Joanne M. Bargman, Dimitrios G. Oreopoulos Intravenous Iron Does Not

More information

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.1.55 The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival Seoung Gu Kim 1 and Nam Ho Kim 2 Department of Internal Medicine,

More information

Peritoneal Solute Transport Rate as an Independent Risk Factor for Total and Cardiovascular Mortality in a Population of Peritoneal Dialysis Patients

Peritoneal Solute Transport Rate as an Independent Risk Factor for Total and Cardiovascular Mortality in a Population of Peritoneal Dialysis Patients Advances in Peritoneal Dialysis, Vol. 30, 2014 Katarzyna Janda, 1 Marcin Krzanowski, 1 Paulina Dumnicka, 2 Beata Kuśnierz Cabala, 3 Przemysław Miarka, 1 Władysław Sułowicz 1 Peritoneal Solute Transport

More information

PART FOUR. Metabolism and Nutrition

PART FOUR. Metabolism and Nutrition PART FOUR Metabolism and Nutrition Advances in Peritoneal Dialysis, Vol. 22, 2006 Costas Fourtounas, Eirini Savidaki, Marilena Roumelioti, Periklis Dousdampanis, Andreas Hardalias, Pantelitsa Kalliakmani,

More information

Predictive Factors for Withdrawal from Peritoneal Dialysis: A Retrospective Cohort Study at Two Centers in Japan

Predictive Factors for Withdrawal from Peritoneal Dialysis: A Retrospective Cohort Study at Two Centers in Japan Advances in Peritoneal Dialysis, Vol. 33, 2017 Yasuhiro Taki, 1 Tsutomu Sakurada, 2 Kenichiro Koitabashi, 2 Naohiko Imai, 1 Yugo Shibagaki 2 Predictive Factors for Withdrawal from Peritoneal Dialysis:

More information

Randomized Controlled Trial of Icodextrin versus Glucose Containing Peritoneal Dialysis Fluid

Randomized Controlled Trial of Icodextrin versus Glucose Containing Peritoneal Dialysis Fluid Randomized Controlled Trial of Icodextrin versus Glucose Containing Peritoneal Dialysis Fluid Aiwu Lin,* Jiaqi Qian,* Xiaomei Li, Xueqing Yu, Wenhu Liu, Yang Sun, Nan Chen, and Changlin Mei,** for the

More information

ad e quate adjective \ˈa-di-kwət\

ad e quate adjective \ˈa-di-kwət\ PD Prescriptions and Adequacy Monitoring: The Basics Fundamentals of Dialysis in Children Seattle, Washington February 27th, 2016 Colin White Steve Alexander Brad Warady Alicia Neu Franz Schaefer Bruce

More information

The peritoneal equilibration test (PET) was developed THE SHORT PET IN PEDIATRICS. Bradley A. Warady and Janelle Jennings

The peritoneal equilibration test (PET) was developed THE SHORT PET IN PEDIATRICS. Bradley A. Warady and Janelle Jennings Peritoneal Dialysis International, Vol. 27, pp. 441 445 Printed in Canada. All rights reserved. 0896-8608/07 $3.00 +.00 Copyright 2007 International Society for Peritoneal Dialysis THE SHORT PET IN PEDIATRICS

More information

Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease

Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease Int Urol Nephrol (2015) 47:1739 1744 DOI 10.1007/s11255-015-1087-9 NEPHROLOGY - ORIGINAL ARTICLE Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease Magdalena Jankowska

More information

CHAPTER 6 PERITONEAL DIALYSIS

CHAPTER 6 PERITONEAL DIALYSIS CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani Hannah Dent Kylie Hurst Stephen McDonald PERITONEAL DIALYSIS ANZDATA Registry 11 Report STOCK AND FLOW AUSTRALIA Peritoneal dialysis was used to

More information

Dialysis therapy remains the mainstay in the treatment

Dialysis therapy remains the mainstay in the treatment Proceedings of the ISPD 2006 The 11th Congress of the ISPD 0896-8608/07 $3.00 +.00 August 25 29, 2006, Hong Kong Copyright 2007 International Society for Peritoneal Dialysis Peritoneal Dialysis International,

More information

CHAPTER 6 PERITONEAL DIALYSIS. Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst Annual Report 35th Edition

CHAPTER 6 PERITONEAL DIALYSIS. Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst Annual Report 35th Edition CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst 212 Annual Report 35th Edition PERITONEAL DIALYSIS ANZDATA Registry 212 Report STOCK AND FLOW AUSTRALIA Peritoneal dialysis

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Optimising small solute clearances in peritoneal dialysis GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Optimising small solute clearances in peritoneal dialysis GUIDELINES Optimising small solute clearances in peritoneal dialysis Date written: August 2004 Final submission: December 2004 GUIDELINES a. Aim to maintain residual renal function (RRF). Consider the use of ace

More information

Original Article Effect of diuretic and ultrafiltration on edema and renal residual function in peritoneal dialysis patients

Original Article Effect of diuretic and ultrafiltration on edema and renal residual function in peritoneal dialysis patients Int J Clin Exp Med 2017;10(2):3321-3328 www.ijcem.com /ISSN:1940-5901/IJCEM0045534 Original Article Effect of diuretic and ultrafiltration on edema and renal residual function in peritoneal dialysis patients

More information

Time trends in initiation and dose of dialysis in end-stage renal disease patients in The Netherlands

Time trends in initiation and dose of dialysis in end-stage renal disease patients in The Netherlands Nephrol Dial Transplant (2003) 18: 552 558 Original Article Time trends in initiation and dose of dialysis in end-stage renal disease patients in The Netherlands Fabian Termorshuizen 1, Johanna C. Korevaar

More information

Survival of Patients Over 75 Years of Age on Peritoneal Dialysis Therapy

Survival of Patients Over 75 Years of Age on Peritoneal Dialysis Therapy Advances in Peritoneal Dialysis, Vol. 26, 2010 Hiromichi Suzuki, Tsutomu Inoue, Yusuke Watanabe, Tomohiro Kikuta, Takahiko Sato, Masahiro Tsuda Survival of Patients Over 75 Years of Age on Peritoneal Dialysis

More information

Obesity predicts long survival in patients on hemodialysis

Obesity predicts long survival in patients on hemodialysis Peritoneal Dialysis International, Vol. 22, pp. 506 512 Printed in Canada. All rights reserved. 0896-8608/02 $3.00 +.00 Copyright 2002 International Society for Peritoneal Dialysis NUTRITION INDICES IN

More information

Correlation of Residual Diuresis with MIS Score and Nutritional Status in Peritoneal Dialysis Patients: A Croatian Nationwide Study

Correlation of Residual Diuresis with MIS Score and Nutritional Status in Peritoneal Dialysis Patients: A Croatian Nationwide Study BANTAO Journal 2015; 13(2): 59-67; doi:10.1515/bj-2015-0014 59 BJ BANTAO Journal Original article Correlation of Residual Diuresis with MIS Score and Nutritional Status in Peritoneal Dialysis Patients:

More information

Chapter 12 PERITONEAL DIALYSIS

Chapter 12 PERITONEAL DIALYSIS Chapter 12 PERITONEAL DIALYSIS B. Sunita A/P V. Bavanandan Anita Bhajan Manocha Lily Binti Mushahar Mohamad Zaimi Bin Abdul Wahab Sudhaharan Sivathasan PERITONEAL DIALYSIS 22nd Report of the SECTION 12.1:

More information

Automated Peritoneal Dialysis is Suitable for Polycystic Kidney Disease Patients with End-Stage Renal Disease

Automated Peritoneal Dialysis is Suitable for Polycystic Kidney Disease Patients with End-Stage Renal Disease Published online: June 20, 2015 2296 9705/15/0052 0140$39.50/0 This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC)

More information

Smart APD prescription. Prof. Wai Kei Lo Tung Wah Hospital The University of Hong Kong

Smart APD prescription. Prof. Wai Kei Lo Tung Wah Hospital The University of Hong Kong Smart APD prescription Prof. Wai Kei Lo Tung Wah Hospital The University of Hong Kong Costing Comparison of Different Modes of RRT in Hong Kong in 2011 (Per Year) HK$300,000 HK$250,000 HK$200,000 HK$150,000

More information

From Peritoneal Dialysis to Hemodialysis How could we improve the transition? Th Lobbedez CHU de Caen Self Dialysis Meeting 22 May 2014

From Peritoneal Dialysis to Hemodialysis How could we improve the transition? Th Lobbedez CHU de Caen Self Dialysis Meeting 22 May 2014 From Peritoneal Dialysis to Hemodialysis How could we improve the transition? Th Lobbedez CHU de Caen Self Dialysis Meeting 22 May 2014 Deux grands principes concernant la DP La dialyse péritonéale doit

More information

Malnutrition and inflammation in peritoneal dialysis patients

Malnutrition and inflammation in peritoneal dialysis patients Kidney International, Vol. 64, Supplement 87 (2003), pp. S87 S91 Malnutrition and inflammation in peritoneal dialysis patients PAUL A. FEIN, NEAL MITTMAN, RAJDEEP GADH, JYOTIPRAKAS CHATTOPADHYAY, DANIEL

More information

PART FOUR. Metabolism and Nutrition

PART FOUR. Metabolism and Nutrition PART FOUR Metaolism and Nutrition Advances in Peritoneal Dialysis, Vol. 19, 2003 Antonios H. Tzamaloukas, 1 Glen H. Murata, 2 Dorothy J. Vanderjagt, 3 Karen S. Servilla, 1 Roert H. Glew 3 Normalization

More information

Brief communication (Original)

Brief communication (Original) Asian Biomedicine Vol. 8 No. 1 February 2014; 67-73 DOI: 10.5372/1905-7415.0801.263 Brief communication (Original) Long-term clinical effects of treatment by daytime ambulatory peritoneal dialysis with

More information

Superior dialytic clearance of b 2 -microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis

Superior dialytic clearance of b 2 -microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis original article http://www.kidney-international.org 26 International Society of Nephrology Superior dialytic clearance of b 2 -microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal

More information

Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: What, Who, Why, and How? Review and Case Study

Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: What, Who, Why, and How? Review and Case Study Advances in Peritoneal Dialysis, Vol. 33, 2017 Kunal Malhotra, Ramesh Khanna Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: What, Who, Why, and How? Review and Case Study

More information

THERAPEUTIC INTERVENTIONS TO PRESERVE RESIDUAL KIDNEY FUNCTION. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle

THERAPEUTIC INTERVENTIONS TO PRESERVE RESIDUAL KIDNEY FUNCTION. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle THERAPEUTIC INTERVENTIONS TO PRESERVE RESIDUAL KIDNEY FUNCTION Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle 1 2 Outline of Presentation Refinements in our understanding

More information

Increased peritoneal dialysis utilization and improved patient survival over a 20-year period: data from a Portuguese Peritoneal Dialysis Unit

Increased peritoneal dialysis utilization and improved patient survival over a 20-year period: data from a Portuguese Peritoneal Dialysis Unit ORIGINAL ARTICLE Port J Nephrol Hypert 2016; 30(2): 113-120 Advance Access publication 30 January 2016 Increased peritoneal dialysis utilization and improved patient survival over a 20-year period: data

More information

Kieran McCafferty 1,2, Stanley Fan 1 and Andrew Davenport 2. clinical investigation. see commentary on page 15

Kieran McCafferty 1,2, Stanley Fan 1 and Andrew Davenport 2. clinical investigation. see commentary on page 15 http://www.kidney-international.org & 2013 International Society of Nephrology see commentary on page 15 Extracellular volume expansion, measured by multifrequency bioimpedance, does not help preserve

More information

Effects of Increased Peritoneal Clearances on Mortality Rates in Peritoneal Dialysis: ADEMEX, a Prospective, Randomized, Controlled Trial

Effects of Increased Peritoneal Clearances on Mortality Rates in Peritoneal Dialysis: ADEMEX, a Prospective, Randomized, Controlled Trial J Am Soc Nephrol 13: 1307 1320, 2002 Effects of Increased Peritoneal Clearances on Mortality Rates in Peritoneal Dialysis: ADEMEX, a Prospective, Randomized, Controlled Trial RAMÓN PANIAGUA,* DANTE AMATO,*

More information

Haemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health

Haemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health Haemodiafiltration - the case against Prof Peter G Kerr Professor/Director of Nephrology Monash Health Know your opposition.. Haemodiafiltration NB: pre or post-dilution What is HDF how is it different

More information

CHAPTER 6 PERITONEAL DIALYSIS. Neil Boudville. Hannah Dent. Stephen McDonald. Kylie Hurst. Philip Clayton Annual Report - 36th Edition

CHAPTER 6 PERITONEAL DIALYSIS. Neil Boudville. Hannah Dent. Stephen McDonald. Kylie Hurst. Philip Clayton Annual Report - 36th Edition CHAPTER 6 Neil Boudville Hannah Dent Stephen McDonald Kylie Hurst Philip Clayton 213 Annual Report - 36th Edition ANZDATA Registry 213 Report STOCK AND FLOW AUSTRALIA Peritoneal dialysis was used to treat

More information

Patient and technique survival on peritoneal dialysis in patients with failed renal allograft: A case control study

Patient and technique survival on peritoneal dialysis in patients with failed renal allograft: A case control study http://www.kidney-international.org & 2006 International Society of Nephrology Patient and technique survival on peritoneal dialysis in patients with failed renal allograft: A case control study S Mujais

More information

PD In Acute Kidney Injury. February 7 th -9 th, 2013

PD In Acute Kidney Injury. February 7 th -9 th, 2013 PD In Acute Kidney Injury February 7 th -9 th, 2013 Objectives PD as a viable initial therapy PD in AKI PD versus dhd PD versus CVVHD Why not PD first PD for AKI Early days (1970 s) PD was the option of

More information

Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function

Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function Nephrol Dial Transplant (2001) 16: 2207 2213 Original Article Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function Murali K. Menon,

More information

Concern about the decreasing use of peritoneal dialysis

Concern about the decreasing use of peritoneal dialysis Page 1 of 8 Peritoneal Dialysis International Peritoneal Dialysis International, Vol. 30, pp. doi: 10.3747/pdi.2008.00277 0896-8608/10 $3.00 +.00 Copyright 2010 International Society for Peritoneal Dialysis

More information

You can sleep while I dialyze

You can sleep while I dialyze You can sleep while I dialyze Nocturnal Peritoneal Dialysis Dr. Suneet Singh Medical Director, PD, VGH Division of Nephrology University of British Columbia Acknowledgements Melissa Etheridge You can sleep

More information

02/21/2017. Assessment of the Peritoneal Membrane: Practice Workshop. Objectives. Review of Physiology. Marina Villano, MSN, RN, CNN

02/21/2017. Assessment of the Peritoneal Membrane: Practice Workshop. Objectives. Review of Physiology. Marina Villano, MSN, RN, CNN Assessment of the Peritoneal Membrane: Practice Workshop Marina Villano, MSN, RN, CNN marina.villano@fmc-na.com Objectives Briefly review normal peritoneal physiology including the three pore model. Compare

More information

Improvement in Pittsburgh Symptom Score Index After Initiation of Peritoneal Dialysis

Improvement in Pittsburgh Symptom Score Index After Initiation of Peritoneal Dialysis Advances in Peritoneal Dialysis, Vol. 24, 2008 Matthew J. Novak, 1 Heena Sheth, 2 Filitsa H. Bender, 1 Linda Fried, 1,3 Beth Piraino 1 Improvement in Pittsburgh Symptom Score Index After Initiation of

More information

Title:Hyperphosphatemia as an Independent Risk Factor of Coronary Artery Calcification Progression in Peritoneal Dialysis Patients

Title:Hyperphosphatemia as an Independent Risk Factor of Coronary Artery Calcification Progression in Peritoneal Dialysis Patients Author's response to reviews Title:Hyperphosphatemia as an Independent Risk Factor of Coronary Artery Calcification Progression in Peritoneal Dialysis Patients Authors: Da Shang (sdshangda@163.com) Qionghong

More information

St George & Sutherland Hospitals PERITONEAL DIALYSIS UNIT RENAL DEPARTMENT Workplace Instruction (Renal_SGH_WPI_097)

St George & Sutherland Hospitals PERITONEAL DIALYSIS UNIT RENAL DEPARTMENT Workplace Instruction (Renal_SGH_WPI_097) PERITONEAL DIALYSIS (PD) PERITONEAL EQUILIBRATION TEST (PET) Cross references NSW Health PD2007_036 - Infection Control Policy SGH-TSH CLIN027 - Aseptic Technique - Competency and Education Requirements

More information

Volume Management 2/25/2017. Disclosures statement: Objectives. To discuss evaluation of hypervolemia in peritoneal dialysis patients

Volume Management 2/25/2017. Disclosures statement: Objectives. To discuss evaluation of hypervolemia in peritoneal dialysis patients Volume Management Sagar Nigwekar MD, MMSc Massachusetts General Hospital E-mail: snigwekar@mgh.harvard.edu March 14, 2017 Disclosures statement: Consultant: Allena, Becker Professional Education Grant

More information

Sequential peritoneal equilibration test: a new method for assessment and modelling of peritoneal transport

Sequential peritoneal equilibration test: a new method for assessment and modelling of peritoneal transport Nephrol Dial Transplant (2013) 28: 447 454 doi: 10.1093/ndt/gfs592 Sequential peritoneal equilibration test: a new method for assessment and modelling of peritoneal transport Magda Galach 1, Stefan Antosiewicz

More information

Intermittent peritoneal dialysis (IPD) has occasionally

Intermittent peritoneal dialysis (IPD) has occasionally Peritoneal Dialysis International, Vol. 32, pp. 142 148 doi: 10.3747/pdi.2011.00027 0896-8608/12 $3.00 +.00 Copyright 2012 International Society for Peritoneal Dialysis INTERMITTENT PERITONEAL DIALYSIS:

More information

Early Initiation of Dialysis Fails to Prolong Survival in Patients with End-Stage Renal Failure

Early Initiation of Dialysis Fails to Prolong Survival in Patients with End-Stage Renal Failure J Am Soc Nephrol 13: 2125 2132, 2002 Early Initiation of Dialysis Fails to Prolong Survival in Patients with End-Stage Renal Failure JAMIE P. TRAYNOR,* KEITH SIMPSON,* COLIN C. GEDDES, CHRISTOPHER J. DEIGHAN,*

More information

Tidal peritoneal dialysis: Comparison of different tidal regimens and automated peritoneal dialysis

Tidal peritoneal dialysis: Comparison of different tidal regimens and automated peritoneal dialysis Kidney International, Vol. 57 (2000), 2603 2607 Tidal peritoneal dialysis: Comparison of different tidal regimens and automated peritoneal dialysis PETER H. JUERGENSEN, A. LOLA MURPHY, KATHY A. PHERSON,

More information

WHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington

WHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have

More information

I. CLINICAL PRACTICE GUIDELINES FOR PERITONEAL DIALYSIS ADEQUACY

I. CLINICAL PRACTICE GUIDELINES FOR PERITONEAL DIALYSIS ADEQUACY I. CLINICAL PRACTICE GUIDELINES FOR PERITONEAL DIALYSIS ADEQUACY GUIDELINE 1. INITIATION OF DIALYSIS 1.1 Preparation for kidney failure: Patients who reach chronic kidney disease (CKD) stage 4 (estimated

More information

PERITONEAL EQUILIBRATION TEST. AR. Merrikhi. MD. Isfahan University of Medical Sciences

PERITONEAL EQUILIBRATION TEST. AR. Merrikhi. MD. Isfahan University of Medical Sciences PERITONEAL EQUILIBRATION TEST AR. Merrikhi. MD. Isfahan University of Medical Sciences INTRODUCTION The peritoneal equilibration test (PET) is a semiquantitative assessment of peritoneal membrane transport

More information

What is a PET? Although there are many types of pets, we will be discussing the Peritoneal Equilibration Test

What is a PET? Although there are many types of pets, we will be discussing the Peritoneal Equilibration Test 1 2 3 What is a PET? Although there are many types of pets, we will be discussing the Peritoneal Equilibration Test 4 Background information about the PET 1983 Dr. Twardowski and colleagues began measuring

More information

When to start dialysis?

When to start dialysis? Nephrol Dial Transplant (2006) 21 [Suppl 2]: ii20 ii24 doi:10.1093/ndt/gfl139 Original Article When to start dialysis? C. E. Douma 1 and W. Smit 2 1 Department of Nephrology, VU University Medical Center,

More information

PRESERVATION OF RESIDUAL RENAL FUNCTION IN DIALYSIS PATIENTS: EFFECTS OF DIALYSIS-TECHNIQUE RELATED FACTORS

PRESERVATION OF RESIDUAL RENAL FUNCTION IN DIALYSIS PATIENTS: EFFECTS OF DIALYSIS-TECHNIQUE RELATED FACTORS Peritoneal Dialysis International, Vol. 21, pp. 52 57 Printed in Canada. All rights reserved. 0896-8608/00 $3.00 +.00 Copyright 2001 International Society for Peritoneal Dialysis PRESERVATION OF RESIDUAL

More information

PD prescribing for all. QUESTION: Which approach? One size fits all or haute couture? (1) or (2)? The patient 18/03/2014.

PD prescribing for all. QUESTION: Which approach? One size fits all or haute couture? (1) or (2)? The patient 18/03/2014. PD prescribing for all Pr Max Dratwa Honorary consultant, Nephrology-Dialysis CHU Brugmann Université Libre de Bruxelles BSN 22 March 2014 QUESTION: Which approach? One size fits all or haute couture?

More information

Clinical Practice Guidelines : 3b - Peritoneal Dialysis. UK Renal Association Clinical Practice Guidelines 5th Edition 2007

Clinical Practice Guidelines : 3b - Peritoneal Dialysis. UK Renal Association Clinical Practice Guidelines 5th Edition 2007 Clinical Practice Guidelines : 3b - Peritoneal Dialysis UK Renal Association Clinical Practice Guidelines 5th Edition 2007 Prof Simon Davies Department of Nephrology University Hospital of North Staffordshire

More information

Evaluation and management of nutrition in children

Evaluation and management of nutrition in children Evaluation and management of nutrition in children Date written: May 2004 Final submission: January 2005 Author: Elisabeth Hodson GUIDELINES No recommendations possible based on Level I or II evidence

More information

New Modality of Dialysis Therapy: Peritoneal Dialysis First and Transition to Home Hemodialysis

New Modality of Dialysis Therapy: Peritoneal Dialysis First and Transition to Home Hemodialysis Advances in Peritoneal Dialysis, Vol. 28, 2012 Hiromichi Suzuki, Hitosi Hoshi, Tsutomu Inoue, Tomohiro Kikuta, Masahiro Tsuda, Tsuneo Takenaka New Modality of Dialysis Therapy: Peritoneal Dialysis First

More information

De Novo Hypokalemia in Incident Peritoneal Dialysis

De Novo Hypokalemia in Incident Peritoneal Dialysis Original investigation 73 1) De Novo Hypokalemia in Incident Peritoneal Dialysis Patients: A 1-Year Observational Study Ji Yong Jung, M.D., Jae Hyun Chang, M.D., Hyun Hee Lee, M.D., Wookyung Chung, M.D.

More information

Quality of sleep in patients with chronic kidney disease

Quality of sleep in patients with chronic kidney disease Nephrol Dial Transplant (2004) 19: 95 99 DOI: 10.1093/ndt/gfg423 Original Article Quality of sleep in patients with chronic kidney disease Eduard A. Iliescu, Karen E. Yeates and David C. Holland Department

More information

Nephrology. Renal Replacement in End-Stage Renal Disease Patients over 75 Years Old. ABC Fax

Nephrology. Renal Replacement in End-Stage Renal Disease Patients over 75 Years Old. ABC Fax American Journal of Nephrology Original Article: Basic Sciences Am J Nephrol 2003;23:7 77 DOI: 0.59/000068040 Received: July 23, 2002 Accepted: October 2, 2002 Renal Replacement in End-Stage Renal Disease

More information

LLL Session - Nutritional support in renal disease

LLL Session - Nutritional support in renal disease ESPEN Congress Leipzig 2013 LLL Session - Nutritional support in renal disease Peritoneal dialysis D. Teta (CH) Nutrition Support in Patients undergoing Peritoneal Dialysis (PD) Congress ESPEN, Leipzig

More information

Predicting Clinical Outcomes in Peritoneal Dialysis Patients Using Small Solute Modeling

Predicting Clinical Outcomes in Peritoneal Dialysis Patients Using Small Solute Modeling 46 Annals of Clinical & Laboratory Science, vol. 35, no. 1, 2005 Predicting Clinical Outcomes in Peritoneal Dialysis Patients Using Small Solute Modeling Justin Westhuyzen, 1 Karen Mills, 2 and Helen Healy

More information

PERITONEAL DIALYSIS CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006

PERITONEAL DIALYSIS CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006 PERITONEAL DIALYSIS CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006 PATIENT IDENTIFICATION [Before completing please read instructions at the bottom of this page and on pages 5 and 6] MAKE CORRECTIONS

More information

METHODS RESULTS. Patients

METHODS RESULTS. Patients ORIGINAL ARTICLE Korean J Intern Med 2014;29:489-497 Ferritin as a predictor of decline in residual renal function in peritoneal dialysis patients Soon Mi Hur, Hye Young Ju, Moo Yong Park, Soo Jeong Choi,

More information

Krediet slide di 18

Krediet slide di 18 1 di 18 Assessment of fluid status in PD patients Raymond T. Krediet, Amsterdam, Netherlands Chairs:Walther H. Boer, Utrecht, The Netherlands F. Fevzi Ersoy, Antalya, Turkey Prof. Raymond T. Krediet DDivision

More information

Improved survival of type 2 diabetic patients on renal replacement therapy in Finland

Improved survival of type 2 diabetic patients on renal replacement therapy in Finland Nephrol Dial Transplant (2010) 25: 892 896 doi: 10.1093/ndt/gfp555 Advance Access publication 21 October 2009 Improved survival of type 2 diabetic patients on renal replacement therapy in Finland Marjo

More information

THE HEMODIALYSIS PRESCRIPTION: TREATMENT ADEQUACY GERALD SCHULMAN MD VANDERBILT UNIVERSITY MEDICAL SCHOOL NASHVILLE, TENNESSEE

THE HEMODIALYSIS PRESCRIPTION: TREATMENT ADEQUACY GERALD SCHULMAN MD VANDERBILT UNIVERSITY MEDICAL SCHOOL NASHVILLE, TENNESSEE THE HEMODIALYSIS PRESCRIPTION: TREATMENT ADEQUACY GERALD SCHULMAN MD VANDERBILT UNIVERSITY MEDICAL SCHOOL NASHVILLE, TENNESSEE THE DIALYSIS CYCLE /TIME DESIGN OF THE NATIONAL COOPERATIVE DIALYSIS STUDY

More information

METABOLISM AND NUTRITION WITH PD OBESITY. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle

METABOLISM AND NUTRITION WITH PD OBESITY. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle METABOLISM AND NUTRITION WITH PD OBESITY Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle 1 Body Size in Patients New to Dialysis United States Body Mass Index, kg/m2 33 31

More information

Peritoneal dialysis adequacy: A model to assess feasibility with various modalities

Peritoneal dialysis adequacy: A model to assess feasibility with various modalities Kidney International, Vol. 55 (1999), pp. 2493 2501 Peritoneal dialysis adequacy: A model to assess feasibility with various modalities JOSE A. DIAZ-BUXO, FRANK A. GOTCH, TOM I. FOLDEN, SHELDEN ROSENBLUM,

More information

Risk of Intradialytic Hypotension in Hemodialysis Patients with Different Residual Urine Volume

Risk of Intradialytic Hypotension in Hemodialysis Patients with Different Residual Urine Volume Journal of Cardiovascular Diseases & Diagnosis ISSN: 2329-9517 Journal of Cardiovascular Diseases & Diagnosis Li et al., J Cardiovasc Dis Diagn 2016, S1:1 DOI: 10.4172/2329-9517.1000S1-005 Research Open

More information

Original Articles. Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis

Original Articles. Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis Nephrol Dial Transplant (2014) 29: 1940 1947 doi: 10.1093/ndt/gfu050 Advance Access publication 3 March 2014 Original Articles Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis

More information

Determination of Peritoneal Transport Characteristics With 24-Hour Dialysate Collections: Dialysis Adequacy and Transport Test1

Determination of Peritoneal Transport Characteristics With 24-Hour Dialysate Collections: Dialysis Adequacy and Transport Test1 Determination of Peritoneal Transport Characteristics With 24-Hour Dialysate Collections: Dialysis Adequacy and Transport Test1 Michael V. Rocco,2 Jean R. Jordan, and John M. Burkart MV. Rocco, J.M. Burkart,

More information